Here we show that the mechanism of action by which h-Prune enhances canonical WNT pathway activation, and its correlation to disease progression, provide the basis for the definition of a new diagnostic marker to detect NSCLC. This evidence concerns the gene PRUNE1 and non-small cell lung carcinoma.